Multidisciplinary Therapy of Pancreas Cancer: recent advances and emerging paradigms

May 8-9, 2020The University of Texas MD Anderson Cancer CenterThe Sheikh Zayed Bin Sultan Al Nahyan Building (Zayed Building)Conference Center, Floor 26565 MD Anderson BoulevardHouston, Texas 77030

educational objectives

After attending the conference, participants should be able to

Implement genetic testing of patients and family members to screen for

those who are at risk for developing pancreatic cancer and other cancers

(knowledge, competence, performance, patient outcomes);

Evaluate, counsel and treat patients with pancreatic cancer at all stages of

disease (locally advanced, resectable, borderline resectable, metastatic)

(knowledge, competence, performance);

Provide a comprehensive understanding of innovative and emerging cancer

therapies, inclusive of the side effects, to the cancer patient (knowledge,

competence, performance, patient outcomes); and

Apprise fellow clinicians and healthcare providers of emerging paradigms

of the latest clinical trials and supportive care (knowledge, competence).

target audience

This conference should be of interest to Physicians, Advanced Practice

Providers, Nurses, Researchers, Fellows and Trainees.

goal

The goal of this activity is

to disseminate information

about the treatments and care

provided for pancreatic cancer

patients and the new research

and technologies implemented,

resulting in improved patient

outcomes.

educational methods

Lectures

Case Study

Question-and-Answer Session

Panel Discussion

evaluation

A course evaluation survey will provide

participants with the opportunity to

comment on the value of the program

content to their practice decisions,

performance improvement activities, or

possible impact on patient health status.

Participants will also have the opportunity

to comment on any perceived commercial

bias in the presentations as well as to

identify future educational topics.

accreditation/ credit designation

The University of Texas MD Anderson

Cancer Center is accredited by the

Accreditation Council for Continuing

Medical Education (ACCME) to provide

continuing medical education for

physicians.

The University of Texas MD Anderson

Cancer Center designates this live activity

for a maximum of 12.00 AMA PRA

Category 1 Credits™. Physicians should

claim only the credit commensurate

with the extent of their participation in

the activity.

abim maintenance of certification (moc)

Successful completion of this CME

activity, which includes participation in

the evaluation component, enables the

participant to earn up to 12.00 Medical

Knowledge MOC points in the American

Board of Internal Medicine’s (ABIM)

Maintenance of Certification (MOC)

program. Participants will earn MOC

points equivalent to the amount of CME

credits claimed for the activity. It is the

CME activity provider’s responsibility to

submit participant completion information

to ACCME for the purpose of granting

ABIM MOC credit.

In order to receive MOC points, you will

need to pass the post-test with a score

of 70% or higher. You will be able to take

the test as many times as you need to in

order to pass.

Participant completion data will be shared

with and transmitted to the ACCME on

the participant’s behalf.

ethics

The “Supportive Care” session has been

designated by The University of Texas MD

Anderson Cancer Center for 1.25 AMA

PRA Category 1 Credits™ in medical

ethics and/or professional responsibility.

cme certificates and attendance verification certificates

Certificates awarding AMA PRA Category

1 Credit™ or certificates documenting

attendance will be emailed when an

individual completed the online CME

Verification and Evaluation Questionnaire

process after the conference.

A record of attendance (certificate) will

be available online to other health care

professionals for requesting credits in

accordance with state nursing boards,

specialty societies, or other professional

associations.

md anderson program committee members

Robert A. Wolff, MD, Co-ChairGastrointestinal Medical Oncology

Matthew HG Katz, MD, Co-ChairSurgical Oncology

Anirban Maitra, MBBSTranslational Molecular, Pathology

Shubham Pant, MBBSInvestigational Cancer Therapeutics

Emma Brae Holliday, MDRadiation Oncology

Sonya TennantSheikh Ahmed Center for Pancreatic Cancer Research

Felisha EstelleCME/Conference Management

Kelley GilpinCME/Conference Management

Pamela Papadopoulos, PhDSheikh Ahmed Center for Pancreatic Cancer Research

Program Agendafriday, may 8, 20203:00 pm Registration

3:30 Welcome & Introductions Robert A. Wolff, MD

3:45 Keynote : Genetics and Targeting Opportunities in Pancreas Cancer Eileen O’Reilly, MD

Translational Talks

4:30 The Role of the Tumor and Gut Microbiome in Pancreatic Cancer Florencia McAllister, MD

5:00 Radiomic Features of Pancreatic Cancer Eugene Koay, MD, PhD

5:30 Liquid Biopsies and Measurement of Therapeutic Response Anirban Maitra, MBBS

6:00 Opportunities for Innovation Through Radiotherapy Clinical Trials for Pancreatic Cancer: The MDACC Experience Cullen Taniguchi, MD, PhD

6:30 Closing Remarks Emma Holliday, MD

6:45 Reception Dinner

saturday, may 9, 20208:00 am Registration and Continental Breakfast

8:30 Welcome & Introductions Matthew HG Katz, MD

8:45 Value Keys from the PC Patient’s Perspective Shannon Magee

9:00 Neoadjuvant Treatment Paradigms for Borderline Resectable and Locally Advanced Pancreatic Cancer: Sequencing and the Role of Radiation Theodore Hong, MD

Current Controversies

9:30 Preoperative vs. Postoperative Therapy for Resectable Pancreatic Cancer Matthew HG Katz, MD Robert A. Wolff, MD

10:00 Should We Treat Oligometastatic Pancreatic Cancer with Local Therapies Chad Tang, MD Ryan Huey, MD

10:30 Break

Multimodality Treatment Paradigms and New Innovations

10:45 Radiographic Staging of Pancreatic Cancer Eric Tamm, MD

11:00 The Role of a Gastroenterologist in Managing Pancreatic Cancer in a Multidisciplinary Approach Jeffrey H. Lee, MD

11:15 Endoscopic Delivery of Novel Therapies in Pancreatic Cancer Manoop Bhutani, MBBS

11:30 Management of Pancreatic Cysts Michael Kim, MD

11:45 Lunch (provided)

12:45 pm Enhanced Recovery after Pancreatic Surgery Ching-Wei Tzeng, MD

1:00 Strategic Approach to Building a Robotic Pancreatic Surgery Program at MD Anderson Naruhiko Ikoma, MD

1:15 Surgery for Borderline Resectable Pancreas Cancer Matthew HG Katz, MD

1:30 “Who, When and How Much?” Current Controversies in Radiation for Pancreatic Cancer Emma Holliday, MD

1:45 Multidisciplinary Tumor Board / Case Study 1 Michael Kim, MD; Michael Overman, MD; and Cullen Taniguchi, MD, PhD

2:00 Break

2:15 Systemic Treatment for Metastatic Pancreatic Cancer, are We Making Headway? Michael Overman, MD

2:30 Update on Novel Targeted Therapies for Pancreas Cancer David Fogelman, MD

2:45 Innovative Early Stage Drug Development Shubham Pant, MBBS

3:00 Multidisciplinary Tumor Board / Case Study 2 Ching-Wei Tzeng, MD; David Fogelman, MD; and Eugene Koay, MD, PhD

3:15 Break

Supportive Care and Survivorship

3:30 Exercise and Pancreatic Cancer Survivorship Nathan Parker, PhD

3:45 Optimizing Nutrition Status in Patients with Pancreatic Cancer Maria Petzel, MBS

4:00 Supportive/Palliative Care for Patients with Pancreatic Cancer Yvonne Heung, MD

4:15 Closing Remarks Shubham Pant, MBBS

4:20 Adjourn

md anderson faculty

guest facultyTheodore S. Hong, MDDirector, Gastrointestinal Service, Radiation Oncology, Massachusetts General Hospital Associate Clinical Director, Radiation Oncology, Massachusetts General Hospital Boston, Massachusetts

Shannon MageePatient Advocate Austin, Texas

Eileen M. O’Reilly, MDWinthrop Rockefeller Endowed Chair in Medical Oncology Section Head, Hepatopancreaticobiliary & Neuroendocrine Cancers Gastrointestinal Oncology Service Associate Director, David M. Rubenstein Center for Pancreatic Cancer Research Attending Physician, Member, Memorial Sloan Kettering Cancer Center, New York, New York Professor of Medicine, Weill Cornell Medical College, New York, New York

Manoop Bhutani, MBBS Professor Gastroenterology, Hepatology & Nutrition

David Fogelman, MD Associate Professor Gastrointestinal Medical Oncology

Yvonne Heung, MD Assistant Professor Palliative Care Medicine

Emma Holliday, MD Assistant Professor, Radiation Oncology

Ryan Huey, MD Assistant Professor Gastrointestinal Medical Oncology

Naruhiko Ikoma, MD Assistant Professor, Surgical Oncology

Matthew HG Katz, MD Associate Professor, Surgical Oncology

Michael Kim, MD Assistant Professor, Surgical Oncology

Eugene Koay, MD, PhD Associate Professor, Radiation Oncology

Jeffrey H. Lee, MD Professor Gastroenterology, Hepatology & Nutrition

Anirban Maitra, MBBS Professor, Pathology, Anatomical

Florencia McAllister, MD Assistant Professor Clinical Cancer Prevention

Michael Overman, MD Professor Gastrointestinal Medical Oncology

Shubham Pant, MBBS Associate Professor Investigational Cancer Therapeutics

Nathan Parker, PhD Instructor, Behavioral Science

Maria Petzel, BS Sr. Clinical Dietitian, Clinical Nutrition

Eric Tamm, MD Professor, Abdominal Imaging

Chad Tang, MD Assistant Professor, Radiation Oncology

Cullen Taniguchi, MD, PhD Assistant Professor, Radiation Oncology

Ching-Wei Tzeng, MD Associate Professor, Surgical Oncology

Robert A. Wolff, MD Professor Gastrointestinal Medical Oncology

registration information

On-site registration for the Multidisciplinary Therapy of Pancreas Cancer Conference opens

at 3:00 p.m. on Friday, May 8, 2020. The opening session will begin at 3:30 p.m. on Friday,

May 8, 2020 and the conference will adjourn at 4:20 p.m., Saturday, May 9, 2020.

Advanced registration is encouraged as space and materials are limited. Please see

registration form for applicable fees.

The deadline for advanced registration is Friday, April 23, 2020.

There are three ways to register:

1. On-line at www.mdanderson.org/conferences

2. Fax to: 713-794-1724

3. Mail to: Department of CME/Conference Management

Unit 1781

The University of Texas MD Anderson Cancer Center

P.O. Box 301407

Houston, TX 77230-1407

We accept the following forms of payment:

1. Check (payable through U.S. banks only)

2. Money Order

3. Credit Cards (MasterCard, VISA, and American Express)

4. Cash (on-site registration only)

When registering online a confirmation letter (receipt) will be automatically emailed to the

email address you list on the registration form. The confirmation letter will serve as your

receipt. If you register by fax or mail, a confirmation letter will be emailed to you within ten

working days of receipt of your fee.

The full conference registration fee includes the tuition, final program, continental

breakfast, breaks, lunch and welcome reception.

refund/cancellation policy

The registration fee, minus a $50

administrative handling fee, is refundable

if a written request is received on or

before April 23, 2020. No refunds will be

granted after that date. The request for a

registration refund must include the tax

identification number of the company or

institution if registration was paid by a

company or institution check.

The Department of CME/Conference

Management reserves the right to cancel

activities prior to the scheduled date, if

low enrollment or other circumstances

make it necessary. Each registrant will be

notified by mail, e-mail, or at the phone

or fax numbers given on the registration

form.

In case of activity cancellation, liability

of the Department of CME/Conference

Management is limited to the registration

fee. The Department of CME/Conference

Management will refund the full

registration fee. The Department of CME/

Conference Management reserves the

right to limit the number of participants

in a program and is not responsible for

any expenses incurred by an individual

whose registration is not confirmed and

for whom space is not available.

For additional information, contact

the Department of CME/Conference

Management at 713-792-2223 or toll free

at 866-849-5866.

special assistance

Contact the Department of CME/

Conference Management at 713-792-

2223 or toll free at 866-849-5866 if

you have any special dietary or ADA

accommodation needs.

accommodations

A block of rooms has been reserved for

conference attendees at the Houston

Marriott Medical Center Hotel, 6580

Fannin Street, Houston, Texas 77030.

Early hotel reservation is suggested.

The hotel phone number is

713-796-0080

Toll Free 1-800-228-9290.

When you make reservations be sure

to mention “Multidisciplinary Therapy

of Pancreas Cancer” to be assured of

receiving the special meeting rate of

$109.00 single or double occupancy.

Please add 17% Texas state and local

taxes.

Room Reservation Website Link:

Book your group rate for

Multidisciplinary Therapy of Pancreas

Cancer Room Block or use the bitly link

https://bit.ly/35mpOfq

Reservations and deposits received

after Thursday, April 23, 2020 will be

confirmed if space is available and at

current hotel published guest room rates.

groundtransportation

Houston is served by two airports, George

Bush Intercontinental (IAH) and William

P. Hobby (HOU). The following forms of

ground transportation are available to and

from the airports to the Medical Center.

Uber and Lyft

Yellow Cab 713-236-1111

Fiesta Cab 713-225-2666

THIS

IS N

OT A

SEL

F-M

AILE

R - A

ddre

ss to

: M

ultid

isci

plin

ary

Ther

apy

of P

ancr

eas

Canc

er:

rec

ent

ad

va

nc

es a

nd e

mer

gin

g p

ar

ad

igm

sM

ay 8

-9, 2

020

Depa

rtmen

t of C

ME/

Conf

eren

ce M

anag

emen

t – U

nit 1

781

The

Unive

rsity

of T

exas

MD

Ande

rson

Can

cer C

ente

r PO

Box

301

407,

Hou

ston

, TX

7723

0-14

07or

fax t

o 71

3-79

4-17

24

Mak

e ch

eck o

r mon

ey o

rder

pay

able

to:

The

Univ

ersi

ty o

f Tex

as M

D An

ders

on C

ance

r Cen

ter

Regi

stra

tion

Fees

Phys

icia

ns/S

cien

tists

Pos

tmar

ked

on o

r bef

ore

April

23,

202

0 . .

. . . .

.$20

0 .00

Pos

tmar

ked

afte

r Apr

il 23

, 202

0 . .

. . . .

. . . .

. . . .

$250

.00

Nur

ses/

APPs

Pos

tmar

ked

on o

r bef

ore

April

23,

202

0 . .

. . . .

. .$7

5 .00

Pos

tmar

ked

afte

r Apr

il 23

, 202

0 . .

. . . .

. . . .

. . . .

$125

.00

Stud

ents

/Fel

low

s/Re

side

nts

Pos

tmar

ked

on o

r bef

ore

April

23,

202

0 . .

. . . .

. .$5

0 .00

Pos

tmar

ked

afte

r Apr

il 23

, 202

0 . .

. . . .

. . . .

. . . .

$100

.00

MDA

CC F

acul

ty P

ostm

arke

d on

or b

efor

e Ap

ril 2

3, 2

020

. . . .

. . .$

150 .

00 P

ostm

arke

d af

ter A

pril

23, 2

020

. . . .

. . . .

. . . .

. .$2

00 .0

0M

DACC

Nur

ses/

APPs

Pos

tmar

ked

on o

r bef

ore

April

23,

202

0 . .

. . . .

. .$5

0 .00

Pos

tmar

ked

afte

r Apr

il 23

, 202

0 . .

. . . .

. . . .

. . . .

$100

.00

MDA

CC S

tude

nts/

Fello

ws/

Resi

dent

s P

ostm

arke

d on

or b

efor

e Ap

ril 2

3, 2

020

. . . .

. . . .

$25 .

00 P

ostm

arke

d af

ter A

pril

23, 2

020

. . . .

. . . .

. . . .

. . .$

75 .0

0At

tend

ing

Frid

ay R

ecep

tion?

. . . .

. . . .

. . . .

. .

Yes

N

o

The University of Texas MD Anderson Cancer Center has implemented a process whereby everyone

who is in a position to control the content of an educational activity must disclose all relevant

financial relationships with any commercial interest that could potentially affect the information

presented. MD Anderson also requires that all faculty disclose any unlabeled use or investigational

use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific

disclosure will be made to the participants prior to the educational activity.

Agendas are subject to change because we are always striving to improve the quality of your

educational experience. MD Anderson may substitute faculty with comparable expertise on rare

occasions necessitated by illness, schedule conflicts, and so forth.

Photographing, audio taping and videotaping are prohibited.

Please let us know what specific topics, issues or questions you wish

to see addressed or emphasized in this activity. Fax or e-mail CME/

Conference Management. All responses will be forwarded to the Program

Chairs for consideration.

CO

NFE

REN

CE

REG

ISTR

ATI

ON

- D12

2369

Mul

tidis

cipl

inar

y Th

erap

y of

Pan

crea

s Ca

ncer

May

8-9

, 202

0La

st N

ame

Firs

tM

IHi

ghes

t Deg

ree

Depa

rtmen

t (in

clud

e un

it no

.) Sp

ecia

lty

Inst

itutio

n

MD

Ande

rson

Em

ploy

ee ID

No.

(req

uire

d fo

r all

MDA

CC e

mpl

oyee

s):

Phys

icia

nn

Yes

n N

o

Stre

et

City

Stat

e/Fo

reig

n Co

untry

/Zip

or M

ail C

ode

Dayt

ime

Phon

e (w

ith a

rea

code

) Ce

ll Ph

one

(with

are

a co

de)

Fax

(with

are

a co

de)

E-m

ail A

ddre

ss (p

leas

e pr

int)

Emer

genc

y Co

ntac

tPh

one

(with

are

a co

de)

Cred

it Ca

rd H

olde

r Nam

e (F

irst/

Last

) Ch

arge

the

follo

win

g:n

VIS

A n

MC n

AM

EX

Cred

it Ca

rd N

umbe

rEx

pira

tion

Date

Secu

rity

Code

/CVV

/CSV

Cred

it Ca

rd H

olde

r Bill

ing

Addr

ess

& Z

IP C

ode

MD

And

erso

n In

terd

epar

tmen

tal T

rans

fer (

IDT)

No .

: *Fu

nd G

roup

90

will

not

be

acce

pted

Bus

ines

s U

nit

Dep

artm

ent

Fund

Gro

up*

Fund

Fund

Typ

e

Aut

hori

zed

Sign

atur

e RE

QU

IRED

for C

RED

IT C

ARD

or I

DT

IDT

Appr

over

Nam

e (F

irst/L

ast)

plea

se p

rint

THIS

IS N

OT A

SEL

F-M

AILE

R - A

ddre

ss to

: M

ultid

isci

plin

ary

Ther

apy

of P

ancr

eas

Canc

er:

rec

ent

ad

va

nc

es a

nd e

mer

gin

g p

ar

ad

igm

sM

ay 8

-9, 2

020

Depa

rtmen

t of C

ME/

Conf

eren

ce M

anag

emen

t – U

nit 1

781

The

Unive

rsity

of T

exas

MD

Ande

rson

Can

cer C

ente

r PO

Box

301

407,

Hou

ston

, TX

7723

0-14

07or

fax t

o 71

3-79

4-17

24

Mak

e ch

eck o

r mon

ey o

rder

pay

able

to:

The

Univ

ersi

ty o

f Tex

as M

D An

ders

on C

ance

r Cen

ter

Regi

stra

tion

Fees

Phys

icia

ns/S

cien

tists

Pos

tmar

ked

on o

r bef

ore

April

23,

202

0 . .

. . . .

.$20

0 .00

Pos

tmar

ked

afte

r Apr

il 23

, 202

0 . .

. . . .

. . . .

. . . .

$250

.00

Nur

ses/

APPs

Pos

tmar

ked

on o

r bef

ore

April

23,

202

0 . .

. . . .

. .$7

5 .00

Pos

tmar

ked

afte

r Apr

il 23

, 202

0 . .

. . . .

. . . .

. . . .

$125

.00

Stud

ents

/Fel

low

s/Re

side

nts

Pos

tmar

ked

on o

r bef

ore

April

23,

202

0 . .

. . . .

. .$5

0 .00

Pos

tmar

ked

afte

r Apr

il 23

, 202

0 . .

. . . .

. . . .

. . . .

$100

.00

MDA

CC F

acul

ty P

ostm

arke

d on

or b

efor

e Ap

ril 2

3, 2

020

. . . .

. . .$

150 .

00 P

ostm

arke

d af

ter A

pril

23, 2

020

. . . .

. . . .

. . . .

. .$2

00 .0

0M

DACC

Nur

ses/

APPs

Pos

tmar

ked

on o

r bef

ore

April

23,

202

0 . .

. . . .

. .$5

0 .00

Pos

tmar

ked

afte

r Apr

il 23

, 202

0 . .

. . . .

. . . .

. . . .

$100

.00

MDA

CC S

tude

nts/

Fello

ws/

Resi

dent

s P

ostm

arke

d on

or b

efor

e Ap

ril 2

3, 2

020

. . . .

. . . .

$25 .

00 P

ostm

arke

d af

ter A

pril

23, 2

020

. . . .

. . . .

. . . .

. . .$

75 .0

0At

tend

ing

Frid

ay R

ecep

tion?

. . . .

. . . .

. . . .

. .

Yes

N

o

Depa

rtmen

t of C

ME/

Conf

eren

ce M

anag

emen

t- Un

it 17

81Th

e Un

iver

sity

of T

exas

MD

Ande

rson

Can

cer C

ente

r17

6700

/30/

1223

69/4

1PO

Box

301

407

Hous

ton,

TX

7723

0-14

07

Non

-Pro

fit O

rg.

U.S.

Pos

tage

P A

I DHo

usto

n, T

XPe

rmit

No.

705

2